Larry Anderson, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Celgene
    Topic:
    Advisory Board activity
    Date added:
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    amgen
    Topic:
    Advisory Board activity
    Date added:
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GSK
    Topic:
    Advisory Board Activity
    Date added:
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Advisory Board Activity
    Date added:
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Advisory Board Activity
    Date added:
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Prothena
    Topic:
    Safety Monitoring committee
    Date added:
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Beigene
    Topic:
    Advisory Board Acivity
    Date added:
    10/25/2022
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Topic:
    Advisory Board Activity
    Date added:
    10/27/2022
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Advisory Board Activity
    Date added:
    10/23/2023
    Date updated:
    08/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cellectar
    Topic:
    Advisory Board Activity
    Date added:
    10/23/2023
    Date updated:
    08/23/2024
Return to 2024 Oncology Year in Review (RP2407A)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.